Last reviewed · How we verify
NCT06366763
Comparative Clinical Efficacy Between Multi-layer Bandage Pressure Therapy and Gradient Pressure Elastic Stocking Treatment After Endovenous Radiofrequency Ablation
NA trial testing Questionnaires in Vascular Diseases, Peripheral in 210 participants. Currently enrolling.
1 August 2024
Quick facts
| Lead sponsor | Chengdu University of Traditional Chinese Medicine |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 210 |
| Start date | 1 August 2023 |
| Primary completion | 1 August 2024 |
| Estimated completion | 1 August 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Questionnaires
Conditions studied
- Vascular Diseases, Peripheral — all drugs for Vascular Diseases, Peripheral →
- Venous Insufficiency of Leg — all drugs for Venous Insufficiency of Leg →
- Varicose Veins of Lower Limb — all drugs for Varicose Veins of Lower Limb →
Sponsor
Chengdu University of Traditional Chinese Medicine
Who can join
Adults 18 to 80, any sex, with Vascular Diseases, Peripheral or Venous Insufficiency of Leg. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Objective: To assess the clinical efficacy of different compression methods within 48 hours after endovenous radiofrequency ablation (RFA) in terms of great saphenous vein closure rate, postoperative complications, quality of life, time to return to normal work, and patient satisfaction.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06366763
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Questionnaires
Trials testing the same drug.
- NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
- NCT07499518 — Fertility and Polycystic Ovary Syndrome · not yet recruiting
- NCT07487844 — Pulsed Electric Field Ablation for Metastatic Breast Cancer · NA · not yet recruiting
- NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
- NCT06836414 — Lung Cancer Screening CT for Firefighters · NA · withdrawn
Other Chengdu University of Traditional Chinese Medicine trials
Trials by the same sponsor.
- NCT07404670 — Microwave Ablation for Treatment of Vascular Malformations: Efficacy and Safety · NA · not yet recruiting
- NCT07239284 — Efficacy and Safety of Endovenous Ablation for Relief of Knee Pain in Elderly Patients With Lower Extremity Varicose Vei · not yet recruiting
- NCT07233616 — Risks and Benefits of Radiofrequency Ablation for Chronic Venous Insufficiency (CEAP C3-C6) in Patients Aged 80 and Over · recruiting
- NCT07163312 — Knee Pain Relief After Endovenous Treatment for Lower Limb Varicose Veins: A Prospective Observational Study · not yet recruiting
- NCT07208695 — Effect of Oral Antiplatelet or Anticoagulant Drugs on Postoperative Bleeding Risk and Venous Closure Rate in Patients Wi · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06366763 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chengdu University of Traditional Chinese Medicine
- Last refreshed: 16 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06366763.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing